country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-W080443

Copy Link Print Information

O-allylvanillin

Kundenbewertung

Based on 1 Customer Validation

O-allylvanillin is O-allylchalcone derivative with anti-cancer effects. O-allylvanillin inhibits THP-1, HL60, Hep-G2, MCF-7 cells growth with IC₅₀ values of 74.76 μM, 63.52 μM, 90.99 μM, and 90.11 μM, respectively.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 98.41%
CAS. Nr.: 22280-95-1
Formel: C₁₁H₁₂O₃
Molecular Weight:192.21

Speicherung:

Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

O-allylvanillin Chemical Structure

CAS. Nr.: 22280-95-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
Reinheit & Dokumentation
Verweise
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

O-allylvanillin is O-allylchalcone derivative with anti-cancer effects^[1]. O-allylvanillin inhibits THP-1, HL60, Hep-G2, MCF-7 cells growth with IC₅₀ values of 74.76 μM, 63.52 μM, 90.99 μM, and 90.11 μM, respectively^[1].

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
ADR5000 cell line	IC₅₀	3.48 μM Compound: 1a	Cytotoxicity against human CEM/ADR5000 cells assessed as reduction in cell viability after 72 hrs by RRA assay Cytotoxicity against human CEM/ADR5000 cells assessed as reduction in cell viability after 72 hrs by RRA assay	[PMID: 33508467]
CCRF-CEM	IC₅₀	14.04 μM Compound: 1a	Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by RRA assay Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by RRA assay	[PMID: 33508467]
HCT-116	IC₅₀	5.77 μM Compound: 1a	Cytotoxicity against human HCT-116 p53+/+ cells assessed as reduction in cell viability after 72 hrs by RRA assay Cytotoxicity against human HCT-116 p53+/+ cells assessed as reduction in cell viability after 72 hrs by RRA assay	[PMID: 33508467]
HCT-116	IC₅₀	8.02 μM Compound: 1a	Cytotoxicity against human HCT-116 p53-/- cells assessed as reduction in cell viability after 72 hrs by RRA assay Cytotoxicity against human HCT-116 p53-/- cells assessed as reduction in cell viability after 72 hrs by RRA assay	[PMID: 33508467]
HepG2	IC₅₀	10.46 μM Compound: 1a	Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by RRA assay Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by RRA assay	[PMID: 33508467]
MDA-MB-231	IC₅₀	14.99 μM Compound: 1a	Cytotoxicity against human MDA-MB-231 pcDNA cells assessed as reduction in cell viability after 72 hrs by RRA assay Cytotoxicity against human MDA-MB-231 pcDNA cells assessed as reduction in cell viability after 72 hrs by RRA assay	[PMID: 33508467]
U-87MG ATCC	IC₅₀	7.5 μM Compound: 1a	Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay Cytotoxicity against human U87 cells assessed as reduction in cell viability after 72 hrs by RRA assay	[PMID: 33508467]

Chemical Information

CAS. Nr. 22280-95-1
Appearance Liquid (Density: 1.084±0.06 g/cm³)
Molecular Weight 192.21
Formel C₁₁H₁₂O₃
Color Colorless to light yellow
SMILES

O=CC1=CC=C(OCC=C)C(OC)=C1
Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Pure form	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : 100 mg/mL (520.25 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

5.2025 mL

26.0127 mL

52.0253 mL

5 mM

1.0405 mL

5.2025 mL

10.4051 mL

10 mM

0.5203 mL

2.6013 mL

5.2025 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (267 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. B Ngameni, et al. Synthesis and evaluation of anticancer activity of O-allylchalcone derivatives. Med chem 2013, 3:3

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	5.2025 mL	26.0127 mL	52.0253 mL	130.0634 mL
	5 mM	1.0405 mL	5.2025 mL	10.4051 mL	26.0127 mL
	10 mM	0.5203 mL	2.6013 mL	5.2025 mL	13.0063 mL
	15 mM	0.3468 mL	1.7342 mL	3.4684 mL	8.6709 mL
	20 mM	0.2601 mL	1.3006 mL	2.6013 mL	6.5032 mL
	25 mM	0.2081 mL	1.0405 mL	2.0810 mL	5.2025 mL
	30 mM	0.1734 mL	0.8671 mL	1.7342 mL	4.3354 mL
	40 mM	0.1301 mL	0.6503 mL	1.3006 mL	3.2516 mL
	50 mM	0.1041 mL	0.5203 mL	1.0405 mL	2.6013 mL
	60 mM	0.0867 mL	0.4335 mL	0.8671 mL	2.1677 mL
	80 mM	0.0650 mL	0.3252 mL	0.6503 mL	1.6258 mL
	100 mM	0.0520 mL	0.2601 mL	0.5203 mL	1.3006 mL

Keywords

100 mg

Angebot einholen Auf Lager

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

O-allylvanillin

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Covalent Screening Library

Cysteine Targeted Covalent Library

Cysteine Targeted Covalent Fragment Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Covalent Screening Library Plus

Bioactive Compound Library

High-Throughput Bioactive Compound Library

Covalent Fragment Library

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

O-allylvanillin

Metabolism/Protease Compound Library

Anti-Cancer Compound Library

Covalent Screening Library

Cysteine Targeted Covalent Library

Cysteine Targeted Covalent Fragment Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Covalent Screening Library Plus

Bioactive Compound Library

High-Throughput Bioactive Compound Library

Covalent Fragment Library

Alle Endogenous Metabolite Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

O-allylvanillin Related Classifications

HY-W080443 Related Classifications